Ensifentrine/Glycopyrronium Bromide

N/A

Report date: 2023/12/28 17:25:54
NME

Base Information

Drug NameEnsifentrine/Glycopyrronium Bromide
Drug Alias NameLAMAEnsifentrine and Glycopyrrolate
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodiesterase 3 inhibitorsPhosphodieterase 4 inhibitorsMuscarinic acetylcholine receptor antagonists
TargetsPhosphodiesterase 3Phosphodieterase 4Muscarinic acetylcholine receptor
Therapy Area/IndicationsPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes EnsifentrineGlycopyrronium Bromide
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVerona Pharma Plc
China Registration ClassN/A

Develop Information

Active CompaniesVerona Pharma Plc
Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic Obstructive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A